Creso Pharma Limited (1X8.F)
Frankfurt - Frankfurt Delayed price. Currency in EUR
Add to watchlist
As of 08:12AM CEST. Market open.
| Previous close | 0.0215 |
| Open | 0.0209 |
| Bid | 0.0209 x 0 |
| Ask | 0.0269 x 0 |
| Day's range | 0.0209 - 0.0209 |
| 52-week range | 0.0209 - 0.1140 |
| Volume | |
| Avg. volume | 495 |
| Market cap | 30.428M |
| Beta (5Y monthly) | 3.19 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -0.0180 |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Simply Wall St.
Even after rising 14% this past week, Creso Pharma (ASX:CPH) shareholders are still down 87% over the past three years
It's nice to see the Creso Pharma Limited ( ASX:CPH ) share price up 14% in a week. But that doesn't change the fact...
- Business Wire
SQZ Biotechnologies Announces Lead Cell Therapy Candidate Induced Radiographic, Symptomatic and Immune Response as Monotherapy in Post-Checkpoint HPV+ Solid Tumor Patient
WATERTOWN, Mass., December 09, 2021--SQZ Biotechnologies Company (NYSE: SQZ), a cell therapy company developing novel treatments for multiple therapeutic areas, today presented interim results from the highest-dose cohort of its ongoing Phase 1/2 clinical trial of lead Antigen Presenting Cell (APC) therapy candidate targeting Human Papillomavirus positive (HPV16+) solid tumors at the European Society for Medical Oncology Immuno-Oncology (ESMO-IO) Congress. Of the five patients in this cohort eva
- Simply Wall St.
Shareholders in Creso Pharma (ASX:CPH) are in the red if they invested three years ago
As an investor, mistakes are inevitable. But really bad investments should be rare. So consider, for a moment, the...
© 2022 Yahoo. All rights reserved.
